Chiesi Farmaceutici to acquire biopharma company Amryt Pharma for $1.5bn

Raghuram Kadari- January 10, 2023 0

Chiesi Farmaceutici, an Italian biopharmaceuticals and healthcare group, has agreed to acquire Amryt Pharma, a commercial-stage biopharmaceutical company, in an all-cash transaction valued at around ... Read More

TWi Biotechnology begins Phase 2 trial for AC-203 in epidermolysis bullosa patients

pharmanewsdaily- October 21, 2018 0

TWi Biotechnology, a Taiwanese biopharmaceutical company, has initiated the enrollment of patients in a pivotal Phase 2 clinical trial evaluating its investigational drug, AC-203, for ... Read More